ReviewESMO open2022

How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain.

A Castañeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.